Abnormal Endothelial Gene Expression Associated With Early Coronary Atherosclerosis.

Robert P. Hebbel,Peng Wei,Liming Milbauer,Michel T. Corban,Anna Solovey,James Kiley,Jack Pattee,Lilach O. Lerman,Wei Pan,Amir Lerman

DOI: https://doi.org/10.1161/jaha.120.016134

IF: 6.106

2020-07-18

Journal of the American Heart Association

Abstract:Background We examined feasibility of a unique approach towards gaining insight into heritable risk for early atherosclerosis: surveying gene expression by endothelial cells from living subjects. Methods and Results Subjects aged <50 years (mean age, 37; range, 22–49) without obstructive coronary artery disease underwent coronary reactivity testing that identified them as having normal or abnormal coronary endothelial function. Cultures of Blood Outgrowth Endothelial Cells (BOEC) from 6 normal and 13 abnormal subjects passed rigorous quality control and were used for microarray assessment of gene expression. Of 9 genes differentially expressed at false discovery rate <0.1%, we here focus upon abnormal subjects having elevated expression of HMGB1 (high mobility group box 1) which we unexpectedly found to be linked to low LAMC1 (laminin gamma 1) expression. This linkage was corroborated by 3 of our past studies and confirmed bio‐functionally. Compared with normal BOEC, abnormal BOEC released 13±3‐fold more HMGB1 in response to lipopolysaccharide; and they deposited one tenth as much LAMC1 into collagen subendothelial matrix during culture. Clinical follow‐up data are provided for 4 normal subjects (followed 13.4±0.1 year) and for 12 abnormal subjects (followed 9.1±4.5 years). Conclusions The known pathogenic effects of high‐ HMGB1 and low‐ LAMC1 predict that the combination would biologically converge upon the focal adhesion complex, to the detriment of endothelial shear responsiveness. This gene expression pattern may comprise a heritable risk state that promotes early coronary atherosclerosis. If so, the testing could be applied even in childhood, enabling early intervention. This approach offers a way to bridge the information gap between genetics and clinical phenotype. Nonstandard Abbreviations and Acronyms BOEC blood outgrowth endothelial cells HMGB1 high mobility group box 1 LAMC1 laminin gamma 1 Clinical Perspective What Is New? Using subjects aged <50 years shown by clinically‐indicated coronary reactivity testing to have either normal or abnormal coronary endothelial function, this feasibility study surveyed gene expression by blood outgrowth endothelial cells (a stable endothelial type that can identify heritable differences in gene expression) to bridge the gap between genomics and clinical phenotype—and has thereby provisionally identified a heritable risk factor for early development of atherosclerosis. Compared with blood outgrowth endothelial cells from subjects having normal coronary endothelial function, blood outgrowth endothelial cells from subjects with abnormal coronary endothelial function exhibited abnormally elevated expression of HMGB1 (high mobility group box 1) that was linked to abnormally depressed expression of LAMC1 (laminin gamma 1). What Are the Clinical Implications? This combination may be a heritable risk factor for early atherosclerosis, since known effects and functions of HMGB1 and LAMC1 predict that their abnormal expression in the observed directions would biologically converge at the focal adhesion complex and endothelial cell membrane in a manner detrimental to the vascular endothelial cell's normal responsiveness to shear stress. Clinical atherosclerosis emerges from complexity involving multiple promotive influences, cell types, and biologic systems. Although heritable factors are believed to account for ≥50% of disease risk, 1 only rarely does this involve a single gene exerting a large influence. Rather, the heritable component of risk most likely involves multiple genes that individually exert smaller effects. Identifying these has been a formidable challenge. We here demonstrate the feasibility of using a unique approach to bridging the information gap between genomics and clinical phenotype: assessing gene expression by endothelial cells obtained from living patients. For this we use blood outgrowth endothelial cells (BOEC) from cultures of peripheral blood. Unlike cell types often labeled "EPC," BOEC are fully differentiated, bona fide endothelial cells that are the in vitro progeny of a circul -Abstract Truncated-

cardiac & cardiovascular systems